The occurrence and the outcomes of the COVID-19 (coronavirus disease-2019) pandemic
have been unprecedented. Worldwide it has infected 4,864,881 people and has caused
321,818 deaths till May 20, 2020.[1] The health care system is confronting an ethical dilemma of scarce resource allocation,
triage of care, and professional duty to care.[2]
[3] Majority of the non-COVID health problems have been neglected. Catering COVID-19,
as well as non-COVID care, is part of robust hospital preparedness and response plan.
The relationship between COVID-19 and urology is multifaceted and dynamic.[4] The rapid surge in the COVID-19 cases has caused redistribution and reorganization
of the health services (including urology). As the pandemic keeps evolving the impact
becomes unpredictable and the benefit often becomes incomprehensible.[5]
[6] In the meantime, the essential and nondeferrable urology care needs a modified but
rational approach. The basis of prioritization and duration of deferral, the consequences
of deferral and delay, the success of alternative modes of medical and surgical treatment
are largely unanswered.[6] The emerging and evolving scientific evidence helps formulating guidelines for urology
case management. This systematic review aims to organize crisis standard evidence
that would assist in informed decision making for a urologist, during COVID-and post-COVID
pandemic era.
Methods
The present systematic review was conducted based on the PRISMA protocol ([Fig. 1]). Online database till May 20, 2020 (Medline, Google Scholar, and EMBASE) was searched
with keywords—“COVID-19,” “SARS-Cov-2,” coronavirus in combination with “Urology.”
The titles and abstracts were independently reviewed by three authors to identify
the potentially related articles. The full texts were reviewed and data summary (the
type of article, place of publication, target topics heading in urology, and recommended
guideline) were tabulated and result generated.
Fig. 1 PRISMA Protocol for Systematic Review.
The studies included were about: (a) general urology care, (b) choice of surgical
modality, (c) triaging urology care, and (d) training. The literature with inaccessible
full-text and non-English research articles was excluded. “Pandemic standard urology
care” and its guiding principles were tabulated.
Results
Out of 63 academic articles, 30 papers are related to general urology care, 16 are
about the benign urological condition, 11 about uro-oncology, and six about urology
training. The majority of the articles are expert opinions and perspectives. Only
16 articles are original research papers. We grouped the research papers according
to the objectives and the information were analyzed to summarize the recommendations.
The current recommendation for pandemic standard urology care is drawn from limited
scientific evidence. The new standard of care exclusively aims to prevent and control
COVID-19 infection, protect occupational health, and optimize scarce resources by
continuing the life and organ saving treatment and interventions. The consensus guidelines
for crisis standard urology care based on the above principles keep evolving as this
pandemic progress.
General Urology Care
The health care system needs to set a clear plan of action in response to COVID-19
pandemic settings ([Table 1]). Minimal risk exposure for the safety of health care workers, fair distribution
and conservation of resources, strategic repurposing of the surgical services including
operating theaters, and professional solidarity among health care workers are necessary
to charter health care during a pandemic.[7]
[8] Reconfiguring elective surgeries conserves resources and provides extra space, stuff,
and, staff for COVID care.[9]
[10] Urological care based on clinical condition and calculated risk provides an ethical
basis of a treatment plan. Inter-department collaboration, transparent communication,
and surge capacity contingency can address unforeseeable challenges during a pandemic.[9] Education and training prepares and motivates health care workers in duty.[5]
[9] Surgical staff can be kept reserve when not required. Telemedicine (patient consultation,
multidisciplinary conference, and electronic database) is a viable option to mitigate
the risk of exposure and contact-free care.[9]
Table 1
General guidelines for urological care during COVID pandemic[4]
[5]
[7]
[8]
[9]
[11]
[14]
[15]
[16]
[20]
[23]
[27]
[29]
[52]
[53]
|
• Ensure adequate essential personal protection equipment.
|
|
• Postpone elective/ nonessential surgeries.
|
|
• Reduce outpatient visit.
|
|
• Triage patients analyzing risk benefit and through informed decision making.
|
|
• Simplify diagnostic and staging process.
|
|
• Education and training of health care staff.
|
|
• Conservation of resources.
|
|
• Reorganization of operation room structure and function.
|
|
• Collaboration among surgical allied unit to find common solution.
|
|
• Prepare contingency plan or surge capacity to meet the emerging crisis.
|
|
• All operative cases should be tested for COVID.
|
|
• Separate COVID-19 positive patients from noninfected patients in each level of care.
|
|
• Procedures in local anesthesia or spinal block whenever possible.
|
|
• Equitable and fair distribution of operation room and the critical care resources.
|
|
• Adopt nonsurgical or open surgical procedure to laparoscopic procedure.
|
|
• Maintain negative room pressure and air filters during minimal invasive procedure.
|
|
• Surgeries should be performed by experienced surgeon outside learning curve.
|
|
• Avoid transrectal diagnostic procedure (ultrasound, digital rectal examination).
|
|
• Consider minimal hospital visit to patients.
|
|
• Defer all types of systemic chemotherapy.
|
Different levels of personal protective equipments are available for health care workers.
Maximum utilization of the personal protective equipment can be done depending upon
the various level of transmission risk (low, moderate, and high).[11]
[12] Operating on COVID-19 positive cases needs adequate planning, precaution, and execution.
The importance of PPE (personal protective equipment), negative pressure room, minimal
personnel movement, disinfection and sterilization, and viral filters was underscored
in mitigating the risk.[4]
[13]
[14]
[15] Emergencies and oncology cases must be continued with judicious use of an operating
room and strained critical care resources.[5]
[9]
[10]
[16] Reorganizing operation theater and rescheduling the surgeries depending upon the
volume of cases, available resources, and expertise allow for efficient patient management
and exposure risk reduction.[7]
[8]
Infection prevention and control is the arduous task in health care settings. The
key steps of the infection control during surgical care are: thorough hand washing,
environmental cleaning, patient decolonization, vascular care, and surveillance. For
environmental control, combination of deep cleaning with surface disinfectants using
quaternary ammonium compound and alcohol is recommended.[17] Sufficient air exchanges (20 cycles per hour) are necessary to reduce the particles
and viral load.[14] For patient decolonization, preoperative chlorhexidine wipes, two doses of nasal
povidone-iodine within 1 hour of incision, and a chlorhexidine mouth rinse are recommended.[17] The standard of sterilization and disinfection for reprocessing instruments should
not be compromised. All endoscopic instruments are subjected to “high-level disinfection”
to kill severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) that causes
COVID-19 disease.[18]
Choice of Surgical Modality
The least invasive intervention modalities that can be completed in local or regional
anesthesia will serve the best interest of patients and urologists.[10]
[14] Endoscopic surgery is considered relatively safe. However, the closed-system suction
evacuation of irrigation fluid is required. Necessary precaution is taken not to cause
iatrogenic trauma that could compromise endourological procedure and its outcome.
Disposable equipment and supplies are preferred over reusable ones.[14] Aerosol generating procedure needs extra precaution and level III personal protection.
Ultrasonic scalpels produce a large amount of water vapor, aerosols, and smoke formation.[19] Monopolar with inbuilt smoke evacuator provides protection. It is highly recommended
to ensure measures to avoid body fluid spillage during surgery and measures to protect
from it.[11]
[14]
[20]
[21] Frequent suction of smoke and use of ultralow particulate air filter (ULPA) are
recommended. Pneumoperitoneum should be set at minimal acceptable pressure. The leak
in pneumoperitoneum should be avoided and prevented. Balloon trocar can prevent air
leak. Laparoscopic trocar and specimen need careful removal when pneumoperitoneum
is still present.[21] The experts are skeptical about the use of two-way insufflations system like air
seal that defy ULPA filter function.[14] Open surgeries are preferred over minimal invasive surgeries (laparoscopic and robotic)
provided the risk does not outweigh the benefit.[19]
[22]
Triaging Urological Care
Triaging the urology services during a pandemic crisis has drawn the attention of
more scholars. The principles guiding the urology care during the COVID-19 pandemic
are listed in [Table 2]. The prioritization and categorization of the urological care are enumerated in
[Table 3]. Experts have proposed prioritization of urological surgeries into five tiers[23] (0, emergency and 4, nonessential) or four tiers[11] [low, high, emergency, and nonessential]) to provide treatment triage during an
ongoing pandemic. The decision of deferring or undertaking urological cases and surgeries
should be guided by public health-focused ethical consideration.[16]
[23] Backed by informed decision, local context, and impact of the global pandemic on
the health system one or the entire four tiers can be stopped, paused, or continued.
Table 2
Principles and ethical values behind urology care triage during pandemic[4]
[11]
[14]
[15]
[16]
[23]
[29]
[45]
[52]
|
• Status of SARS-CoV-2 test and COVID-19 disease condition.
|
|
• Trend of pandemic in local context and calculated risk of exposure.
|
|
• Disease severity or stage.
|
|
• Prognosis by deferring.
|
|
• Available alternative treatment modalities.
|
|
• Resources (human, capital, and infrastructure) availability and utilization.
|
|
• Expected total hospital stay, recovery, and number of follow-up visit.
|
|
• Expected complications and strain to the critical care unit.
|
|
• Risk of exposure during referral or deferral.
|
Abbreviations: COVID-19, coronavirus disease 2019; SARS-CoV-2, severe acute respiratory
syndrome coronavirus 2.
Table 3
Urology care triage and recommendation[5]
[11]
[16]
[22]
[23]
[29]
[31]
[32]
[38]
[39]
[40]
[42]
[43]
[44]
[45]
[49]
[50]
|
Nondeferrable/Emergency/Life threatening
|
Deferrable for 3–6 mo
|
Active surveillance
|
Consider medical therapy (Chemo/Hormonal/Immunotherapy)
|
Deferred till pandemic ends or ≥6 mo
|
|
Uro-oncology
|
|
1. Associated gross hematuria.
2. Ca penis (T2-T4).
3. Groin dissection in node positive carcinoma penis (<4 cm, mobile).
4. High-risk UTUC.
5. MIBC (T2-T3, Any N).
6. High-risk bladder cancer.
7. RCC with hematuria and renal or IVC involvement.
8. Post chemotherapy RPLND.
9. Intravesical BCG in high-risk NMIBC.
|
1. Ca penis (Tis, Ta, T1).
2. Low-risk CaP.
2. Intermediate risk CaP.
3. High-risk CaP (consider neoadjuvant hormonal therapy).
4. Low-risk UTUC.
5. Low and intermediate risk bladder cancer.
6. Asymptomatic RCC.
7. Good and intermediate IMDC risk RCC (neoadjuvant target therapy).
8. Suspected adrenal tumor.
9. Intravesical therapy for low and intermediate NMIBC.
|
1. Groin negative ca penis (low and intermediate risk).
2. Fixed, >4 cm Groin node in carcinoma penis.
3. Testicular tumor (CS-I).
4. Selected low-risk CaP.
|
1.Fixed, >4 cm node in Ca penis-chemotherapy.
2. Testicular tumor
(CS-IS, CSII, CS-III)-chemotherapy.
3.Metastatic CaP and CRPC—complete androgen blocked.
4.CRPC
5. Metastatic bladder cancer (consider immunotherapy).
6. Metastatic RCC-target therapy.
7. Wilm's tumor.
|
|
|
Urological emergencies
Testicular torsion, Fournier gangrene, obstructed uropathy (with or without infection),
acute urinary retention, clot retention, urethral injury, penile fracture, trauma,
infected prosthesis, and priapism.
|
Outpatient procedures
Prostate biopsy, Office cystoscopy, pressure flow studies, stent, or nephrostomy change,
intravesical therapy in low-risk bladder cancer.
|
|
Benign prostatic enlargement, Lower ureteral stone <10 mm.
|
Non essential and low priority Elective Surgeries
Uncomplicated urolithiasis, Reconstructive surgeries, Surgery for infertility, prosthesis
surgery, Surgeries of BEP
|
|
Cadaveric renal transplant
|
Systemic chemotherapy
|
|
Living Donor Renal Transplant
|
|
Benign disease
Ureteral stone without obstruction.
PUJO with stable function.
Recto/pubo urethral fistula
|
|
Hands on Residency training
|
|
Pediatric urology:
|
|
Urosepsis with obstruction trauma with hemodynamically unstable, malignant testicular,
or paratesticular tumor, rhabdomyosarcoma of bladder or prostate, testicular torsion,
paraphimosis, obstructed hernia.
|
cryptorchidism, high-risk VUR.
Progressive loss of function in PUJO and obstructed megaureter, PUV, stone disease
with febrile UTI, Wilm's tumor.
|
|
High-risk Wilm's tumor-chemotherapy.
|
Hydrocele, inguinal hernia, circumcision, incontinence surgery, meatotomy, botulinum
injections: hypospadias, buried penis, bladder augmentation and diversion. Pyeloplasty
without loss of differential function, VUR, uncomplicated urolithiasis
|
Abbreviations: BCG, Bacillus Calmette–Guérin; BEP, benign enlargement of prostate;
Ca, carcinoma; CaP, carcinoma prostate; CRPC, castrations resistant prostate cancer;
CS, clinical stage; IMDC, International metastatic RCC database consortium; IVC, inferior
vena cava; MIBC, muscle invasive bladder cancer; NMIBC, nonmuscle invasive bladder
cancer; PUJO, pelviureteric junction obstruction; PUV, posterior urethral valve; RCC,
renal cell carcinoma; RPLND, Retroperitoneal lymph node dissection; UTI, urinary tract
infection; UTUC, upper tract urothelial carcinoma.
Outpatient Urology Care
The outpatient visits should be reduced to a minimum. Progressively deteriorating
disease conditions or organ or life-threatening conditions are only recommended to
visit the urology clinic. “Telehealth-integrated patient management protocol” is encouraged.[24]
[25] Virtual clinics have been proposed for the continuation of essential outpatient
care. Radiological investigation and cystoscopy for an emergency condition like gross
hematuria and urosepsis should not be deferred.[26]
The office-based diagnostic procedures (flexible cystoscopy, pressure flow studies)
for the benign condition can be deferred. The outpatient urological procedures like
prostate biopsy follow-up cystoscopy, replacement of ureteral stents and nephrostomy
tube, and intravesical therapy for low-risk nonmuscle invasive bladder cancer (NMIBC),
and NMIBC patients who have already completed 1 year of maintenance therapy can be
deferred.[16]
[23]
[27]
[28] However, the risk and benefit need to be evaluated with informed decision making.[5]
[11]
Emergency Urological Care
Urological emergencies are either organ threatening or life threatening and cannot
be deferred. Necessary personal protective measures are taken before embarking on
interventions. Consideration is given to the least invasive procedure with a minimum
operative time that can be conducted in the local or regional anesthetic block. The
majority of these emergency urological conditions are minor surgeries, endourological,
and percutaneous procedures done under local or regional anesthesia without delay.[11]
[23]
[29] Tefik et al advise to manage obstructing urolithiasis depending upon the status
of renal function, infection, and pain.[30]
Uro-Oncology
The majority of the urological malignancies are given high priority and the required
intervention is strongly recommended.[16]
[23]
[29]
[31] Urological surgeries can be triaged on basis of the COVID-19 test, cancer stage,
the outcomes of delaying, and the provision of alternative treatment modalities.[16]
[31] One-third to two-third of the planned oncology surgeries have been rescheduled during
the COVID-19 pandemic.[11]
[22]
[23]
[31] Systemic chemotherapy is better avoided due to high risk of immunosuppression. Alternative
therapies like immunotherapy, target therapy, and hormonal therapy are considered
safer. Radiotherapy that requires repeated health care center visit is discouraged.[22]
[27] Intravesical therapy for bladder cancer is strictly limited to the high-risk groups.[11]
[28]
[32] Interventional diagnostic and follow-up procedures for the low-risk in terms of
outcome (prostate biopsy, surveillance cystoscopy, and intravesical therapy) can be
deferred safely.[5]
[11]
[29] Low-risk disease that otherwise can be taken for surgeries can be put on active
surveillance.[22]
Benign Urological Condition
Except for emerging complications, the majority of the benign urological condition
can be postponed until the pandemic ends.[15] Nonurgent urolithiasis intervention can be deferred. But urolithiasis with symptoms
and complications required urinary diversion or symptomatic relief.[30] All types of surgeries for benign prostatic enlargement (endoscopic and minimal
invasive) are classified nonessential and the acute condition can be managed with
temporary bladder diversion.[16] A serious concern is made by academician regarding men's health.[33]
[34]
[35] Witherspoon and colleagues recommended individual consideration for care of: male
infertility, testicular mass, testicular pain, sperm banking, and testicular deficiency
syndrome.[36]
[37]
Elective renal transplant surgery is not advisable during the acute phase of the current
pandemic.[15]
[38] Ritschl et al[39] has elaborately mentioned about the recommendation for both donor and recipients
of solid organ transplant including kidney. Complete epidemiological, clinical, and
laboratory investigation of the donor and recipients are strongly recommended. No
active COVID-19 cases should be considered for transplant surgery. Deceased donor
transplantation (even from recovered COVID-19 cases) needs careful consideration.[16]
[39]
Residency Training
Urology residency training is compromised as the services are reduced and limited
to nondeferrable cases. It has caused stress among medical students as all the medical
examinations and academic rounds are currently postponed.[15] However, online presentation, discussion and telecast; simulation training; and
virtual congressional meeting are actively fulfilling the gap and are popularly in
the practice.[40]
[41] This pandemic is going to be there for quite a long time before any therapeutic
or chemopreventive measure is discovered. Nassar and colleagues recommended the “functional-restructuring”
of the residency program in the era of COVID pandemic to optimize the patient care
and maintain the morale of residents.[42] Continued medical education to update the COVID-19 knowledge and skills (including
critical care, palliative care, resource conservation, and ongoing clinical trials)
is necessary. Residents need to care for personal safety and mental health; adopt
telehealth and virtual learning; and supplement training with medical ethics, health
policy, and global health.[43] Fifty-five percent of the urologist in training in France reported mental stress
due to COVID pandemic.[44] Maintaining the healthy reserve of residents is necessary to mitigate burn out.[43]
Discussion
Guidelines Office Rapid Response Group (GORRG) of European Association of Urology
(EAU) has divided the elective urological surgeries based on clinical harm down the
timeline (low risk, no harm by 6 months; intermediate risk, no harm by 3 to 4 months,
and high risk, no harm by 6 weeks).[45] The epidemiology of COVID-19 is rapidly changing and unpredictable. The effect of
rescheduling the procedures can have a unique clinical outcome in each patient and
is not easy to predict exactly for a span of timeframe. Risk of contracting and spreading
the infection and benefiting the individual patient should be cautiously balanced.
Prioritizing the urological care and selecting the modality of surgical intervention
during this pandemic should be based upon available scientific evidence and local
socioeconomic context.[10]
[16]
[31] We should not forget that the best available armamentarium for primary prevention
is social distancing and personal protection equipment. The “test-trace-isolate” is
another effective secondary prevention modality. Infectivity and mortality of SARS-CoV-2
virus need to be understood well. The 30-day postoperative outcomes were reported
by the COVIDsurg collaborative from the international cohort (24 countries). They
found 71.5% (806 out of 1,128) SARS-CoV-2 infection and 51.2% of pulmonary complications
in the postoperative period with an overall mortality rate of 23.8%. The risk factors
for complications were older age (>70 years), male gender, emergency surgeries, and
malignant surgeries.[46] The overall worldwide mortality rate ranges from 2.3 to 5.6% and significantly higher
in the age group >80 years (8%).[14] The SARS-CoV-2 virus was also isolated from stool and urine (6.9%) of the COVID
positive patient.[47]
[48]
Urological malignancy and the transplant candidates are most vulnerable to the disease
progression as well as to the COVID-19 exposure.[16]
[39] The major triaging criteria for malignancy are its prognosis and provision of alternative
treatment modalities and utilization of resources.[16] It requires informed clinical decisions and contingency. Active screening of the
malignancy is not recommended.[22] The shortage of intravesical therapeutic agents for NMIBC (BCG - Bacillus Calmette–Guérin)
can be addressed by using the alternative agent (mitomycin c) in selected cases or
by reducing the dosage of the intravesical BCG to half to one-third.[49] The emergency conditions need to be managed efficiently and effectively without
adding the extra risk of exposure and extra burden to health care resources. Human
is both victim and vector of SARS-CoV-2. No age is immune. Pediatric urology too needs
pandemic standard care.[24]
[50] Higher risk population group should avoid visiting the outpatient department. Malignant
diseases are at higher risk than benign (p = 0.001).[40] Telemedicine (video visit, virtual check-in, eVisit, and eConsult) not only provides
zero risk urology services during a pandemic but also has the potential to grow into
telemonitoring (cystoscopy, video-urodynamic, radiodiagnosis) and telesurgery (robotic
surgery).[51] Based upon the risk grading, a study in Germany found that 54.1% of the patients
in Germany were eligible (based on risk grading) and willing for tele-consultation
for urology care that will ensure “contact-free continuity of care”.[25] Besides convenience, efficiency, and cost-utility the long-term quality health care
(efficacy, safety, and equity) provided by the telehealth is not known.[51] All the urologists including the residents in urology should quickly learn and adopt
the changing context of the health care system to serve patients and to save themselves.[42]
[43]
[44]
We have included the current scientific evidence and academic articles in this review
to make it comprehensive and simple. Evidence-based health care is the integration
of research studies, clinical experiences, expert opinions, and patient values. The
lower level (expert's opinion and consensus statements) of current evidence justifies
the crisis standard approach. This is not the first and probably not the last pandemic
of this world. Our review would provide important guidance and motivation for further
scientific research to frame robust urology preparedness and response plan. Current
evidence and guidelines are based on high-impact countries, mainly Europe and the
United States (60%). This reserves room for reporting and publication bias and wider
external validity. Further experiences and evidence from all corners of the world
could help to draw more suitable and adoptable consensus among urologists worldwide.
Observing and deferring what we currently assume nonessential could add new insight
to the natural history of the disease.
Conclusion
Balancing the crisis standard public health protection and individual clinical care
is a big challenge. Triaging urology care is the best approach during a public health
crisis. Informed decision making in health care has paramount importance during a
pandemic. The COVID-19 pandemic has provided ample opportunity to learn, unlearn,
and relearn the science. It is also time to plan a resilient health care system appropriate
for the public health crisis which could afflict humankind time and again.
